InsidersTradesSigma
Browse the complete record of transactions filed by 권영이, Chairman & CEO. Director active across 2 companies, notably 삼익제약. Cumulatively, 1 disclosures have been logged. The latest transaction was filed on 26 March 2026 (Purchase). Regulator: DART (FSS). The full history is free.
1 of 1 declaration
Kwon Young-hee is the chairman and CEO of Samik Pharmaceutical. In this role, he is responsible for the strategic and operational direction of the company. Samik Pharmaceutical specializes in the pharmaceutical sector. Kwon Young-hee plays a crucial role in guiding and growing the company.